Member Info for ogm4

Great to see more and more attention in the US for GDR's product

Massive market

Labcompare

- The Buyer's Guide for Laboratory Equipment

Headquarters in  San Francisco, US

They just wrote an article about AIHL:...

4th Apr

https://www.labcompare.com/617-News/584811-Rapid-Bedside-Genotype-Test-Can-Prevent-Hearing-Loss-in-Newborns/

It's coming folks...

All good, a well deserved re-rate

37.50 paid

Medical Device Network

April 4, 2022

Genedrive develops new genetic test to prevent deafness in babies

https://www.medicaldevice-network.com/news/genedrive-genetic-test-prevent-deafness-babies/

USA inquiries are linked via contact New York

Inspiration Healthcare

@InspHealthcare

Proud to be the sole distributors for this fantastic device in the UK which reduces the likelihood of induced hearing loss! #neonatalcare #genedrive #hearingloss

https://mobile.twitter.com/InspHealthcare/status/1510933293381951488

genedrive plc
@genedriveplc
·
33 min

#GDR For any sales enquiries of the NEW Genedrive MT-RNR1 ID test in the UK please contact our distributor

@InspHealthcare

Genedrive's twitter is on fire today!...

£85k trade gone through

Here we go

Look at the share trade counter in overdrive!...

Cheers Username, GDR is progressing well as we speak.

Genedrive sending out 4 tweets or so on a regular Saturday, I can't recall many companies in the past doing active PR over the weekend.

They must be over the moon!

genedrive plc @genedriveplc
2 hr

Inspiration Healthcare have now launched our Genedrive AIHL test for sale in the UK

#GDR #IHC

@InspHealthcare

#neonatalcare

https://mobile.twitter.com/genedriveplc/status/1510193287944146944

NHS Develops World-First Bedside Genetic Test To Prevent Babies Going Deaf

2 April

https://www.manchester.ac.uk/discover/news/nhs-develops-world-first-bedside-genetic-test-to-prevent-babies-going-deaf/

Medical specialists / doctors are thrilled, it's only a matter of time.

https://mobile.twitter.com/paul_rx8/status/1509850095247888385

New Scientist tweet out about GDR

https://mobile.twitter.com/newscientist/status/1509811581651243012

AIHL is a unique product c/w proven high reliability and accuracy.
It has never been possible to rapidly perform the test in an emergency care situation before Genedrive's advancement.
So GDR could become global product leader unique in its kind standing pround above the rest of the market.

Worldwide market is stated appr. 7-9 million neonates per year.
Commercial revenue could be potentially a lot higher than 80 GBP per test, who knows. Especially when you can save multiples on alternative treatment methods in case of absence of any competitors.

Plus also:
There might be more than one test per patient required.
Like an additional validation test a certain time period later on - for full confirmation purposes.

Yes, this could be a one billion + pound market overall easily.

up we go

Remember AIHL:

"sufficiently rapid technology to support clinical decision making"

Very good test performance:
• real-world analytical sensitivity of 100%
• a specificity of 99.2%
• accuracy of 99.2%.
• performance rate of 94.3%

Keep on stacking that gold!..... :-)